Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc.
- Market cap
- $1.55M
Your view on CDIOW
Overview
What the company does, where it operates, and who runs it.
About Cardio Diagnostics Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Meeshanthini V. Dogan
- Headquarters
- 311 West Superior Street, Chicago, IL, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Meeshanthini V. Dogan
- Headquarters
- 311 West Superior Street, Chicago, IL, US
Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk.
Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cardio Diagnostics Holdings, Inc.. Starting points for Cardio Diagnostics Holdings, Inc.: EPS -$2.19, beta 2.18 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cardio Diagnostics Holdings, Inc.. Trailing twelve-month EPS for Cardio Diagnostics Holdings, Inc. stands at -$2.19. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cardio Diagnostics Holdings, Inc.. Cardio Diagnostics Holdings, Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | Healthcare | NYSE | $1.9B | ||
| BICTFBiocure Technology Inc. | Healthcare | OTC | $379,088 | ||
| BIOABioAge Labs, Inc. | Healthcare | NASDAQ | $161.1M | ||
| BIOAFBioasis Technologies Inc. | Healthcare | OTC | $15,883 | ||
| BIORQBiora Therapeutics, Inc. | Healthcare | PNK | — | ||
| BIT.AXBiotron Limited | Healthcare | ASX | — | ||
| BITRFBiotron Limited | Healthcare | OTC | $29.2M | ||
| BIVIBioVie Inc. | Healthcare | NASDAQ | $8.6M | ||
| BIXTBioxytran, Inc. | Healthcare | OTC | $3.6M | ||
| BLAB.CNBritannia Life Sciences Inc. | Healthcare | CNQ | $13.0M | ||
| BLEGBranded Legacy Inc | Healthcare | OTC | $542,622 | ||
| BLRXBioLineRx Ltd. | Healthcare | NASDAQ | $4.8M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Cardio Diagnostics Holdings, Inc. executives and directors. Shares of Cardio Diagnostics Holdings, Inc. have traded between $0.01 and $0.02 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cardio Diagnostics Holdings, Inc.. Coverage tracks Cardio Diagnostics Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cardio Diagnostics Holdings, Inc.